Target intelligence / Profile preview

T-cell factor 1 (Tcf1)

Target
Tcf1
Molecular classification
Transcription factor, High mobility group (HMG) box transcription factor, Wnt signaling effector
01

Overview

T-cell factor 1 (Tcf1) is a high mobility group (HMG) box-containing transcription factor encoded by the TCF7 gene, belonging to the TCF/LEF family. It functions as a key mediator of the canonical Wnt/β-catenin signaling pathway and plays a critical role in T-cell lineage specification, development, and differentiation. Tcf1 acts as both a transcriptional activator (when associated with β-catenin) and repressor (when associated with Groucho co-repressor), determining T-cell fate by regulating expression of lineage-defining genes such as GATA3 and BCL11B. Tcf1 is essential in embryonic development, stem cell biology, and immune cell function, and its dysregulation is implicated in cancer, autoimmune disease, and immunodeficiencies. It is increasingly studied as a disease biomarker and potential therapeutic target, especially in oncology and immune therapies. For further granularity, specify which TCF/LEF family member or isoform is being referenced (e.g., Tcf1 vs. Tcf4). "T-cell factor" by itself is too general for precise drug targeting or scientific characterization, so the entry should be corrected to "T-cell factor 1 (Tcf1)" for canonical usage.

Other names
TCF1TCF-1TCF7 (gene name)T-cell-specific transcription factor 1T-cell factor (generic, but ambiguous)TCF/LEF family (refers to the broader group)
02

Mechanism of action

Modulation of Wnt/β-catenin signaling Transcriptional activation/repression of target genes (e.g., GATA3, BCL11B)

03

Biological functions

Regulation of T-cell developmentCell fate specificationSignal transduction (via Wnt pathway)Cell proliferationChromatin remodelingGene expression regulation
04

Disease associations

Cancer (including roles in tumorigenesis and tumor suppression)InflammationAutoimmune diseaseDiabetesOther (embryonic development defects, immunodeficiencies)
05

Safety considerations

Broad impact on stem cell and immune cell fate—potential for off-target effects, aberrant immune responses, or impaired lymphocyte developmentRisk of unintended Wnt pathway modulation leading to tumorigenesis or developmental defects
06

Interacting drugs

No approved drugs directly listed as Tcf1 modulators; agents modulating Wnt/β-catenin signaling (e.g., PRI-724, CWP232291) indirectly affect Tcf1 function. Targeting Tcf1 is under research in cancer and immune modulation.
07

Biomarkers

Tcf1 expression levels in T-cells as markers for T-cell lineage fidelityTcf1+ stem-like CD8 T cells as predictive biomarkers for response to immunotherapy

Beyond the preview

Go deeper on T-cell factor 1 (Tcf1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell factor 1 (Tcf1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call